Adeel discusses the evolution of gene therapy, highlighting the setbacks faced due to past failures. He introduces an innovative approach using mini circles—plasmids derived from bacteria that offer a reversible and benign alternative to traditional viral therapies. This groundbreaking technology promises to minimize risks while effectively targeting specific peptides or enzymes in the body, marking a significant advancement in the field.
